Search Result "atherogenic conditions."


Research Article

Novel Monocyte Biomarkers of Atherogenic Conditions

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 3 Year: 2013 Page: 5859-5864
Author(s): Alexei Gratchev, Ilja Ovsiy, Ioannis Manousaridis, Vladimir Riabov, Alexander Orekhov, Julia Kzhyshkowska

Review Article

PPAR Agonists, Atherogenic Dyslipidemia and Cardiovascular Risk

Journal: Current Pharmaceutical Design
Volume: 23 Issue: 6 Year: 2017 Page: 894-902
Author(s): Dragana Nikolic,Giuseppa Castellino,Maciej Banach,Peter P. Toth,Ekaterina Ivanova,Alexander N. Orekhov,Giuseppe Montalto,Manfredi Rizzo

Atherogenic Versus Non-atherogenic Lipoprotein Profiles in Healthy Individuals. Is There a Need to Change Our Approach to Diagnosing Dyslipidemia?

Journal: Current Medicinal Chemistry
Volume: 21 Issue: 2 Year: 2014 Page: 2892-2901
Author(s): S. Oravec, A. Dukat, P. Gavornik, M. Kucera, K. Gruber, L. Gaspar, M. Rizzo, P.P. Toth, D.P. Mikhailidis, M. Banach

Blood Serum Atherogenicity and Coronary Artery Calcification

Journal: Current Pharmaceutical Design
Volume: 20 Issue: 3 Year: 2014 Page: 5884-5888
Author(s): Igor A. Sobenin, Veronica A. Myasoedova, Elena V. Anisimova, Xenia N. Pavlova, Stefan Mohlenkamp, Axel Schmermund, Rainer Seibel, Sina Berenbein, Nils Lehmann, Susanne Moebus, KarlHeinz Jockel, Alexander N. Orekhov, Raimund Erbel

Blood Atherogenicity as a Target for Anti-atherosclerotic Therapy

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 3 Year: 2013 Page: 5954-5962
Author(s): Igor A. Sobenin, Dimitry A. Chistiakov, Yuri V. Bobryshev, Anton Y. Postnov, Alexander N. Orekhov

The Anti-Atherogenic Effects of Thiazolidinediones

Journal: Current Diabetes Reviews
Volume: 3 Issue: 1 Year: 2007 Page: 67-74
Author(s): Lily Stojanovska, Suzy Y. Honisett, Paul A. Komesaroff

The Atherogenic Dyslipidemia of Metabolic Syndrome- Are there New Effective Therapeutic Options Beyond Statins?

Journal: Current Drug Therapy
Volume: 2 Issue: 3 Year: 2007 Page: 177-195
Author(s): Giovanni Anfossi, Mariella Trovati

“European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses

Journal: Current Vascular Pharmacology
Volume: 9 Issue: 5 Year: 2011 Page: 533-571
Author(s): Dimitri P. Mikhailidis, Moses Elisaf, Manfredi Rizzo, Kaspar Berneis, Bruce Griffin, Alberto Zambon, Vasilios Athyros, Jacqueline de Graaf, Winfried Marz, Klaus G. Parhofer, Giovam Battista Rini, Giatgen A. Spinas, Gerald H. Tomkin, Alexandros D. Tselepis, Anthony S. Wierzbicki, Karl Winkler, Matilda Florentin, Evangelos Liberopoulos

Adiponectin - A Novel Anti-Atherogenic Factor in the Metabolic Syndrome: Mechanisms of Action and Therapeutic Potential

Journal: Vascular Disease Prevention
Volume: 2 Issue: 2 Year: 2005 Page: 107-114
Author(s): Yehuda Kamari, Irit Avni, Ehud Grossman, Yehonatan Sharabi

A Review of the Cardiovascular and Anti-Atherogenic Effects of Ghrelin

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 2 Year: 2013 Page: 4953-4963
Author(s): Manfredi Rizzo, Ali A. Rizvi, Emina Sudar, Sanja Soskic, Milan Obradovic, Giuseppe Montalto, Mohamed Boutjdir, Dimitri P. Mikhailidis, Esma R. Isenovic

Previous   Next

Go To   Results 1 - 1 of 1792

Filter Result

Volume Year
Ads
© 2022 Bentham Science Publishers | Privacy Policy